Liver and Man Boobs: Causes and Treatment
Liver problems and man boobs are more closely connected than many people realise. Gynaecomastia, the medical term for enlarged breast tissue in men, can develop when liver disease disrupts the body's ability to process and clear hormones, leading to a rise in oestrogen relative to testosterone. This hormonal imbalance stimulates breast tissue growth and is particularly associated with liver cirrhosis and alcohol-related liver disease. This article explains the mechanism behind this link, what other causes to consider, how gynaecomastia is diagnosed, and what treatment options are available on the NHS.
Summary: Liver disease can cause gynaecomastia (man boobs) by impairing oestrogen clearance and reducing free testosterone, creating a hormonal imbalance that stimulates breast tissue growth.
- Liver cirrhosis and alcohol-related liver disease are recognised medical causes of gynaecomastia in adult men.
- The liver clears oestrogen from the bloodstream; when damaged, oestrogen accumulates and the oestrogen-to-testosterone ratio rises.
- True gynaecomastia involves glandular breast tissue, not fat, and presents as a firm disc of tissue beneath the nipple.
- Many medicines, including spironolactone, finasteride, and anabolic steroids, can also cause gynaecomastia independently of liver disease.
- Sudden, one-sided, or painful breast swelling with skin changes or nipple discharge requires prompt GP assessment to exclude breast cancer.
- Reducing alcohol intake and maintaining a healthy body weight are the most impactful lifestyle changes for liver-related gynaecomastia.
Table of Contents
- Can liver problems really cause man boobs?
- How does the liver affect hormone balance in men?
- What other conditions or medicines can cause gynaecomastia?
- How is gynaecomastia diagnosed and what tests will my GP arrange?
- What treatments are available on the NHS for man boobs?
- Lifestyle changes that may help your liver and hormone levels
- Scientific References
- Frequently Asked Questions
Can liver problems really cause man boobs?
Yes, liver disease causes gynaecomastia by impairing oestrogen clearance and raising the oestrogen-to-testosterone ratio, stimulating true glandular breast tissue growth, not simply fat accumulation.
Yes, liver disease can cause gynaecomastia (the medical term for enlarged breast tissue in men), and this connection is well recognised in clinical practice. The liver plays a central role in processing and clearing hormones from the bloodstream, and when it is damaged or diseased, this function is impaired. As a result, oestrogen levels can rise relative to testosterone, creating a hormonal environment that stimulates breast tissue growth.
Chronic liver conditions, particularly liver cirrhosis, are among the more common medical causes of gynaecomastia in adult men.[1][2] Alcoholic liver disease is especially associated with this effect, partly because alcohol itself can suppress testosterone production and partly because of the liver damage it causes.
It is important to understand that gynaecomastia caused by liver disease involves true glandular breast tissue, not simply fat accumulation (which is called pseudogynaecomastia). On examination, true gynaecomastia typically presents as a firm, rubbery disc of tissue concentric with the nipple and areola, which helps distinguish it from fatty tissue.[1][2] The distinction matters because the two conditions have different causes and different management approaches. If you notice breast swelling or tenderness, it is worth speaking to your GP rather than assuming it is harmless, as it can occasionally signal an underlying condition that needs investigation.
How does the liver affect hormone balance in men?
The liver regulates male hormone balance by clearing oestrogen and producing SHBG; in cirrhosis, impaired clearance and increased SHBG reduce free testosterone, raising the oestrogen-to-androgen ratio.
The liver regulates male hormone balance primarily by producing sex hormone-binding globulin (SHBG) and by metabolising and clearing oestrogens from the body. When the liver is functioning normally, it breaks down excess oestrogen efficiently, keeping the ratio of oestrogen to testosterone within a healthy range.
In chronic liver disease such as cirrhosis, SHBG levels are typically increased rather than reduced. Because SHBG binds testosterone preferentially, a higher SHBG level means less free (biologically active) testosterone is available, even when total testosterone appears normal or only mildly reduced. At the same time, the damaged liver clears oestrogen less efficiently, allowing it to accumulate in the circulation. Together, these changes produce a raised oestrogen-to-androgen ratio that can stimulate breast tissue growth.
Aromatisation, the conversion of androgens into oestrogens, occurs predominantly in peripheral tissues, particularly adipose (fat) tissue, rather than primarily in the liver.[4] In liver disease, the contribution of impaired oestrogen clearance and altered hormone binding is the main driver of hormonal imbalance, though increased peripheral aromatase activity may also play a role.
Alcohol adds another layer of complexity. It can directly suppress the testes' ability to produce testosterone and reduce the liver's capacity to clear oestrogen.[3][5] This means that men with alcohol-related liver disease face multiple simultaneous mechanisms driving a raised oestrogen-to-androgen ratio, which is why gynaecomastia is particularly prevalent in this group.
Hormonal imbalance from liver disease can also affect other aspects of male health, including libido, energy levels, and fertility. These broader effects are worth discussing with a GP or specialist if they are a concern, as they may point to the need for further investigation of liver function.
| Cause Category | Examples | Mechanism | Key Features | Action |
|---|---|---|---|---|
| Liver disease | Cirrhosis, alcoholic liver disease | Impaired oestrogen clearance, raised SHBG reducing free testosterone | Firm glandular tissue concentric with nipple; true gynaecomastia | Liver function tests, manage underlying liver condition, stop alcohol |
| Alcohol use | Chronic heavy drinking | Directly suppresses testicular testosterone production and impairs oestrogen clearance | Often coexists with liver disease, compounding hormonal imbalance | Reduce or stop alcohol; follow UK Chief Medical Officers' 14-unit weekly guideline |
| Hormonal conditions | Hypogonadism, hyperthyroidism, testicular or adrenal tumours | Reduced androgen production or excess oestrogen secretion | May present with other systemic symptoms; testicular exam essential | Testosterone, LH, FSH, thyroid function, tumour markers; urgent referral if tumour suspected |
| Prescribed medicines | Spironolactone, finasteride, antipsychotics, digoxin, anti-androgens, some antiretrovirals | Anti-androgenic effects, raised prolactin, or oestrogen-like activity | Onset often correlates with starting or increasing the medicine | Review medication list with GP; do not stop prescribed medicines without advice |
| Anabolic steroid misuse | Exogenous anabolic steroids | Converted peripherally to oestrogen via aromatisation | Growing cause in younger men; effects can persist after stopping use | Cease use; seek GP assessment; specialist referral may be needed |
| Kidney failure | Chronic renal disease | Disrupted hormone metabolism, similar to liver disease | Usually part of broader systemic illness | Renal function tests (urea and electrolytes); manage underlying renal condition |
| Physiological (normal) | Newborns, puberty, older age | Transient hormonal fluctuations at key life stages | Bilateral, self-limiting; no associated systemic disease | Reassurance and observation; investigate if persistent or atypical features present |
What other conditions or medicines can cause gynaecomastia?
Gynaecomastia has many causes including hypogonadism, hyperthyroidism, kidney failure, and medicines such as spironolactone, finasteride, anabolic steroids, and certain antipsychotics.
Gynaecomastia has many causes beyond liver disease, and identifying the underlying reason is an important part of clinical assessment. Hormonal conditions are among the most common, including hypogonadism (low testosterone production), hyperthyroidism, and tumours of the testes or adrenal glands that produce oestrogen or oestrogen-like hormones. Kidney failure, like liver disease, can disrupt hormone metabolism and lead to breast tissue enlargement.
Medicines are a particularly important and often overlooked cause. A wide range of commonly prescribed drugs can trigger gynaecomastia, including:
-
Spironolactone, used for heart failure and fluid retention, which has anti-androgenic effects[28]
-
Cimetidine, an older acid-suppressing medicine
-
Some antipsychotics and antidepressants, which can raise prolactin levels
-
Anabolic steroids, which are converted to oestrogen in the body
-
Digoxin, used in heart conditions
-
Finasteride and dutasteride, used for benign prostatic enlargement and hair loss
-
Anti-androgens (such as bicalutamide) and GnRH agonists, used in prostate cancer treatment
-
Some antiretroviral medicines (for example, efavirenz)
-
Certain calcium-channel blockers (for example, verapamil and nifedipine)
If you think a prescribed medicine may be contributing to breast tissue changes, do not stop taking it without first speaking to your GP or prescriber, as stopping abruptly can be harmful.
Recreational drugs including cannabis and alcohol can also contribute, though the evidence for cannabis is based on limited studies and should be interpreted cautiously. Anabolic steroid misuse is a growing cause of gynaecomastia in younger men, and the effects can persist even after stopping use.
Physiological gynaecomastia, which is not caused by disease, occurs normally in newborns, during puberty, and in older age, and usually resolves without treatment.
Contact your GP promptly if breast swelling appears suddenly, is painful, is one-sided, or is accompanied by any of the following features, which require further evaluation to rule out breast cancer (which, though rare, can occur in men): a hard or irregular lump, nipple retraction or inversion, blood-stained nipple discharge, skin tethering or dimpling, or enlarged lymph nodes in the armpit. These features align with the criteria used in NICE guidance on suspected cancer (NG12) to identify those who need urgent specialist assessment.
How is gynaecomastia diagnosed and what tests will my GP arrange?
Diagnosis involves clinical history, physical examination, and blood tests including liver function, testosterone, oestradiol, LH, FSH, thyroid function, prolactin, and tumour markers such as beta-hCG.
Gynaecomastia is diagnosed through a combination of clinical history, physical examination, and targeted investigations, and your GP is the right first point of contact. During the consultation, your GP will ask about the duration and progression of the breast swelling, any associated symptoms such as pain or nipple discharge, your full medication list (including supplements and recreational substances), alcohol intake, and any personal or family history of relevant conditions.
On examination, your GP will assess whether the tissue is true glandular breast tissue or fatty tissue, and will check for any discrete lumps, skin changes, or lymph node enlargement that might suggest a more serious cause. They will also examine the testes, as testicular tumours are an important cause to exclude. If a testicular tumour is suspected, urgent referral under the NICE NG12 suspected cancer pathway should not be delayed to await blood test results.
Blood tests are usually arranged to assess:
-
Liver function tests (LFTs), to evaluate liver health
-
Renal function (urea and electrolytes), as kidney disease is also a recognised cause
-
Testosterone (ideally measured in an early-morning sample) and oestradiol levels, to assess the hormonal balance
-
Luteinising hormone (LH) and follicle-stimulating hormone (FSH), to evaluate pituitary and testicular function
-
Thyroid function tests
-
Prolactin, particularly if medicines affecting dopamine are involved
-
Beta-hCG and alpha-fetoprotein, tumour markers that can indicate a testicular or other germ cell tumour
If a testicular abnormality is suspected, an ultrasound scan will be arranged. For breast imaging in men, ultrasound is generally the first-line modality; mammography may be used in addition depending on clinical features, age, and local protocols. NICE NG12 guidance supports a two-week-wait referral to a breast clinic if there are suspicious features such as a hard or irregular mass, nipple retraction, blood-stained discharge, or skin changes, ensuring prompt specialist assessment where needed.[16]
What treatments are available on the NHS for man boobs?
NHS treatment depends on the underlying cause; options include addressing the trigger, off-label tamoxifen prescribed by a specialist for recent-onset cases, or surgical reduction for longstanding fibrotic tissue.
Treatment for gynaecomastia on the NHS depends on the underlying cause, the duration of the condition, and the degree of physical or psychological impact it is having. Addressing the root cause is always the first priority. If a medicine is responsible, your GP may be able to switch you to an alternative, but do not stop any prescribed medicine without medical advice. If liver disease is the driver, managing the liver condition, including stopping alcohol if relevant, is central to treatment.
For gynaecomastia that has been present for less than one to two years, the glandular tissue may still be responsive to hormonal treatments. Tamoxifen, a selective oestrogen receptor modulator, is sometimes used off-label in this context by a specialist, though it is not licensed specifically for gynaecomastia in the UK.[17][18] Tamoxifen carries recognised risks including an increased risk of venous thromboembolism (blood clots), hot flushes, and other side effects; prescribing, monitoring, and follow-up should be led by a specialist.[21][22] Tamoxifen and similar medicines are prescription-only and should not be obtained online without a valid prescription and appropriate clinical oversight. If you experience any suspected side effects from a medicine, you can report them to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk. Prescribing decisions are made on an individual basis, and NHS availability may vary depending on local Integrated Care Board (ICB) commissioning decisions.
For longstanding gynaecomastia (typically present for more than two years), the breast tissue tends to become fibrotic and is unlikely to respond to medical treatment. In these cases, surgical reduction (subcutaneous mastectomy or liposuction, depending on the tissue composition) may be considered. However, NHS funding for surgery is subject to local ICB criteria, and in many areas it is only commissioned where there is significant documented psychological or physical impact. Your GP can advise on the referral pathway in your area.
Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online consultations with prescriber review and pharmacist support, where clinically appropriate options may be discussed as part of a broader assessment. Psychological support, including referral to talking therapies, may also be appropriate where gynaecomastia is causing significant distress.
Lifestyle changes that may help your liver and hormone levels
Reducing alcohol intake is the most impactful change, as alcohol damages the liver and suppresses testosterone; maintaining a healthy weight also reduces aromatase activity and improves hormone balance.
Reducing alcohol intake is the single most impactful lifestyle change for men whose gynaecomastia is linked to liver disease or alcohol use, as alcohol both damages the liver and directly suppresses testosterone production. The UK Chief Medical Officers' Low Risk Drinking Guidelines advise that men should not regularly drink more than 14 units of alcohol per week, and that these units should be spread across at least three days.[23] For men with established liver disease, complete abstinence is usually recommended by their specialist.
Maintaining a healthy body weight is also important. Excess body fat, particularly around the abdomen, increases aromatase activity in adipose tissue, which converts testosterone into oestrogen. Losing weight through a balanced diet and regular physical activity can help reduce this conversion and improve the testosterone-to-oestrogen ratio. The UK Chief Medical Officers' physical activity guidelines recommend at least 150 minutes of moderate-intensity aerobic activity per week, alongside strength training on two or more days.[24][25]
Diet quality matters for liver health specifically. A diet rich in vegetables, wholegrains, lean protein, and healthy fats, and low in ultra-processed foods, added sugars, and saturated fat, supports liver function and reduces the risk of metabolic dysfunction-associated steatotic liver disease (commonly known as fatty liver disease or NAFLD), which is increasingly common and can impair hormone metabolism over time.
Avoiding anabolic steroids and other performance-enhancing substances is essential, as these are a significant and preventable cause of gynaecomastia. Some herbal supplements, including those containing phytoestrogens or lavender and tea tree oil (in topical products), have been associated with hormonal effects in case reports, though the evidence is limited and largely based on small numbers of cases.[26] If you are taking any supplements, it is worth discussing them with your GP or pharmacist to check for potential hormonal interactions.
Scientific References
- Gynecomastia and cirrhosis of the liver.
- Gynecomastia and Cirrhosis of the Liver.
- Testosterone and alcoholic cirrhosis. Epidemiologic, pathophysiologic and therapeutic studies in men.
- Estrogen production and action.
- Time-dependent effects of alcohol on the hypothalamic-hypophyseal-testicular function in the rat.
- Finasteride | Drugs - BNF - NICE.
- Dutasteride | Drugs - BNF - NICE.
- Analysis of Data From Breast Diseases Treated With 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia.
- MHRA strengthens safety warnings for finasteride and dutasteride.
- Efavirenz-induced grade III gynecomastia in an HIV-positive male patient: a case report and literature review.
- Gynaecomastia in the Durban Breast Unit: A Comparison of HIV- and Non-HIV-Infected Individuals.
- Breast abnormalities in adolescents receiving antiretroviral therapy.
- Verapamil hydrochloride | Drugs - BNF - NICE.
- Adverse Drug Reactions Advisory Committee. Gynaecomastia in association with calcium antagonists.
- Gynecomastia associated with calcium channel blocker therapy.
- Suspected cancer: recognition and referral (NG12).
- Tamoxifen | Drugs - BNF - NICE.
- Off-label use of tamoxifen in a Chinese tertiary care hospital.
- Tamoxifen for the management of breast events induced by non-steroidal antiandrogens in patients with prostate cancer: a systematic review.
- Off-label or unlicensed use of medicines: prescribers' responsibilities.
- Tamoxifen 20mg Film-Coated Tablets – Summary of Product Characteristics.
- Tamoxifen and risk of idiopathic venous thromboembolism.
- Alcohol consumption: advice on low risk drinking.
- UK Chief Medical Officers' physical activity guidelines.
- Physical activity guidelines for adults aged 19 to 64.
- Prepubertal Gynecomastia Linked to Lavender and Tea Tree Oils.
- Symptoms of breast cancer in men.
- Aldosterone antagonists in hypertension and heart failure.
Frequently Asked Questions
Can improving liver health reduce gynaecomastia caused by liver disease?
Treating the underlying liver condition, including stopping alcohol completely if alcohol-related liver disease is the cause, can help restore hormonal balance and may reduce gynaecomastia, particularly if the breast tissue has not yet become fibrotic.
When should I see a GP about enlarged breast tissue?
See your GP promptly if breast swelling is sudden, painful, one-sided, or accompanied by a hard lump, nipple retraction, blood-stained discharge, or skin changes, as these features require urgent assessment to exclude breast cancer.
Is surgery for gynaecomastia available on the NHS?
NHS surgery for gynaecomastia is available in some areas but is subject to local Integrated Care Board criteria, and is generally only funded where there is significant documented psychological or physical impact; your GP can advise on the referral pathway in your area.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Any third-party brands or services referenced on this site are included for informational purposes only; we are entirely independent and have no affiliation, partnership, or collaboration with any companies mentioned.






